| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
18 companies
Glazer Capital, LLC serves as a 10% Owner at SLAMF and has filed Form 4s across 18 companies. Across recent SEC filings that breaks down to 1 buy and 179 sells. Those positions are worth an estimated $294.0M at current prices.
Historically, Glazer Capital, LLC's trades have earned a middling insider score of 69/100 across 22 rated trades. Over a 12-month horizon, 36.4% of those trades were profitable, with an average 12-month return of +22.9%.
The biggest single holding is SLAMF (~$58.5M) as 10% Owner. The recent filings there lean toward selling, a net 1,824,706 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2020 | HLLY Holley Inc. | 10% Owner | Sell | 100 | $9.98 | $998.00 | - | |
| Oct 20, 2020 | HLLY Holley Inc. | 10% Owner | Sell | 81,606 | $9.95 | $811,856.82 | -2.5% | |
| Oct 19, 2020 | 10% Owner | Sell | 25,000 | $10.35 | $258,750.00 | -1.5% | ||
| Oct 15, 2020 | 10% Owner | Sell | 405,983 | $10.36 | $4,206,883.88 | -20.0% | ||
| Oct 12, 2020 | REVB Revelation Biosciences, Inc. | 10% Owner | Sell | 9,348 | $10.00 | $93,480.00 | -0.9% | |
| Oct 12, 2020 | HLLY Holley Inc. | 10% Owner | Sell | 134,100 | $9.90 | $1,327,090.00 | -4.0% | |
| Sep 29, 2020 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 10% Owner | Sell | 2 | $11.50 | $23.00 | - | |
| Sep 22, 2020 | 10% Owner | Sell | 50,000 | $10.96 | $548,000.00 | -2.4% | ||
| Sep 21, 2020 | JSPR Jasper Therapeutics, Inc. | 10% Owner | Sell | 1,000 | $10.00 | $10,000.00 | - | |
| Sep 18, 2020 | 10% Owner | Sell | 8,169 | $10.54 | $86,101.28 | -0.4% |